CAVU Biotherapies, Inc. – Trademark Portfolio
Entity Type: 03
CAVU Biotherapies, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CAVU BIOTHERAPIES. The owner is based in Houston, TX.
8285 El Rio, Suite 110
Houston, TX 77054
Showing of trademarks Trademarks
Trademark Classifications
CAVU Biotherapies, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does CAVU Biotherapies, Inc. have?
CAVU Biotherapies, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 2 cancelled.
What trademark classes does CAVU Biotherapies, Inc. file in?
CAVU Biotherapies, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are CAVU Biotherapies, Inc.'s most well-known trademarks?
CAVU Biotherapies, Inc.'s registered trademark portfolio includes well-known marks such as CAVU BIOTHERAPIES. These are among 1 currently registered trademark in the portfolio.
What is CAVU Biotherapies, Inc.'s trademark registration success rate?
CAVU Biotherapies, Inc. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.